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Pregnancy and Lactation Labeling Rule
FDA. Content and Format of Labeling for Human Prescription Drug and Biological 
Products Requirements for Pregnancy and Lactation Labeling
• Changes in Content and Format 
– Removes pregnancy letter categories
– Requires label to be updated when information is outdated
– Requires information about pregnancy exposure registries when 
available
Pregnancy and Lactation Labeling Rule
• 8.1- information for a pregnancy exposure registry, risk summary, clinical 
considerations, and data.  Information previously listed in the “Labor and 
delivery” subsection is here.
• 8.2- Section renamed, information about using the drug while breastfeeding, 
amount of drug in breastmilk and potential effects on infant.
• 8.3- New to labeling, information about need for pregnancy testing, 
contraceptive recommendations and infertility.
8.1 Pregnancy
8.3 Nursing Mothers 8.3 Females and Males of 
Reproductive Potential
8.2 Lactation (includes Nursing Mothers)
8.1 Pregnancy (includes Labor and Delivery)
The word is out…
…COPD is common...
…so we’re diagnosing it…
…a lot…
…but maybe too much?
Collins BF et a. Factors predictive of airflow obstruction 
among veterans with presumed empirical diagnosis and 
treatment of COPD. Chest 2015;147:369.
“All that wheezes is not asthma (or COPD!)”
• About 1/3 of patients with a diagnosis of COPD have 
had spirometry
• The goal of this study: determine what factors are 
associated with a diagnosis of COPD
• In their cohort of about 5,000 patients with a chart 
diagnosis of COPD and receiving bronchodilator 
therapy
– Only 55% had air flow obstruction on subsequent 
spirometry
• Absence of airflow obstruction more likely if:
– Obese
– comorbidities such as HF, OSA, DM or depression
Age + smoking = no guarantee
36 % of persons with a 25 pack-year history of smoking 
will develop COPD
So, what’s the harm in not getting spirometry? 
• The authors argue:
– Delaying diagnosis of the true cause of dyspnea
– Adverse effects of unnecessary treatment
– Cost of unnecessary treatment 
Prevnar 13
• For all adults ≥65 years of age, recommend 
pneumococcal vaccination 
• Vaccination for such individuals should now 
consist of two vaccines (PCV13 and PPSV23) 
administered sequentially, with the sequence 
and timing dependent on whether the patient 
had previously received PPSV23
• The CAPiTA trial >> trial to determine efficacy of 
Prevnar 13 in adults
• Compared PCV13 to placebo in 85,000 
immunocompetent adults > 65
- Done in Netherlands
- 45% efficacy of PCV13 against 
vaccine-type pneumococcal 
pna
- 45% efficacy against vaccine 
type nonbacteremic
pneumococcal pna
- 75% efficacy against  vaccine 
type invasive pneumococcal 
disease
• The 23-valent pneumococcal polysaccharide 
vaccine (PPSV23) has been recommended for 
many years in the United States for all adults 
≥65 years of age. 
• In September 2014, the United States 
Advisory Committee on Immunization 
Practices (ACIP) began also recommending 
PCV13 for all adults ≥65 years of age
• Medicare has started to pay for this
Sequential administration and recommended intervals for PCV13 
and PPSV23 for adults aged ≥65 years — Advisory Committee on 
Immunization Practices, United States
• We should Now be giving our elderly patients 
BOTH PCV13 and PPSV23 pneumococcal 
vaccines. Yes, both are now recommended 
for 65 and older
• If they had PPSV23, they should now receive 
PCV13, YES, but need interval of at least one 
year when pt received PPSV23 first.
• but if starting new, give the PCV13 first, then 
PPSV23 YES, but need interval of at least 8 
weeks when pt received PCV13 first. (Best if 
6-12 months, and can be more)
Hypertension in Pregnancy
Magee LA et al. Less-tight vs. tight control of hypertension in pregnancy. NEJM 2015
• In open-label, multicenter study,  987 pregnant women with 
chronic or gestational HTN randomized to
– Less-tight (diastolic goal 100 mm Hg)
– Tight (diastolic goal 85 mm Hg)
• Labetalol was recommended initial drug
Hypertension in Pregnancy
• No difference in
– Serious maternal complications
– Pregnancy loss
– Low birth weight
– NICU need
• Women in tight control group were less likely to 
have
– low platelet counts (1.6 vs 4.3%)
– Elevated LFT (1.8 vs 4.3%)
– Severe HTN (28 vs 41%)
“The way to a man’s heart is through his 
stomach.” – Ibuprofen, 1994
Olsen AMS et al. Association of NSAID Use With 
Risk of Bleeding and Cardiovascular Events in 
Patients Receiving Antithrombotic Therapy After 
Myocardial Infarction. JAMA. 2015;313(8):805.
The study
• Just over 60,000 patients with first MI 
identified from 2002 – 2011 and followed for 
3.5 years on average.
• Average age 67.7 years; 63% men.
• Of theses, 34% had at least one NSAID script
• Outcomes: bleeding requiring hospitalization 
and composite CV outcome (CV death, 
recurrent MI, stroke)
Interesting side note…
• Why do we get all these awesome population 
studies out of Denmark? 
• Danish National Registry of Patients enacted in 
1977
• Denmark has universal health coverage
• Physician payment tied to use of national registry
• Registry includes all physicians, pharmacies, and 
hospitals in the country
• Ethics committee approval is not required for 
retrospective registry studies. Take that, IRB!
Results
Copyright © 2015 American Medical 
Association. All rights reserved.
Moral of the story
• Composite CV risk was also increased: HR 1.40 
(95% CI, 1.30-1.49). 
• NNH for bleeding ~ 50, for CV event ~ 33
• An increased risk of bleeding and 
cardiovascular events was evident with 
concomitant use of NSAIDs, regardless of 
antithrombotic treatment, types of NSAIDs, or 
duration of use.
To Pack or Not to Pack
- In 1996, U.S. ED’s cared 
for 1.2 million 
abscesses 
- This increased to 3.3 
million visits in 2005. 
- Few studies to support 
packing, but is a 
common practice

Wound Packing
• One hundred pediatric patients with subcutaneous abscesses 
were enrolled between May, 2008 and December, 2010. 
• All underwent incision and drainage, then seven days of oral 
antibiotics and warm soaks. 
• Patients were randomized to the packing group (PG) or non-
packing group (NPG). Packing was removed 24h after the 
procedure. 
• Patients were evaluated in clinic if recurrence was suspected 
during follow-up calls on postoperative days seven and 30.
The two groups were not statistically 
different with respect to initial 
parameters, recurrent abscesses (one 
in each group), or MRSA incidence 
(81.4% PG/85.7% NPG).
Not a huge study, but can consider 
not packing abscesses that are less 
than 6cm in diameter but have them 
return in 2 or 3 days to see what 
happens. 
2015 Dietary Guidelines
• Dietary Guideline Advisory Committee 
– USDA and DHHS
– Guided by:
• Half of adults have preventable chronic disease and 2/3 are 
overweight or obese
• Health-related lifestyle behaviors are influenced by personal, 
social, organizational, environmental fx and these factors 
must be addressed to affect change
• Data sources 
– NHANES
– Prevalence and trends in health conditions
2015 Dietary Guidelines
• Underconsumed nutrients:
– Vitamins A, D*, E, C, folate
– Minerals calcium*, magnesium, potassium *(and 
iron in adolescent and premenopausal adult 
women)
– Fiber*
• Overconsumed nutrients:
– Sodium
– Saturated fat
New Dietary Guidelines
• 2015 Dietary Guidelines for Americans
– Limitations on cholesterol intake (previously 300 
mg per day) removed.
– Limit daily consumption of 
• Added sugars <10%
• Saturated fat <10% calories
• Sodium <2300 mg
– Half of grain intake  should be whole grains
– Moderate alcohol and caffeine intake fine in most 
adults
2015 Dietary Guidelines
• Majority of US pop has low intake of food groups 
that are key sources of shortfall nutrients
– Vegetables
– Fruits
– Whole grains
– Dairy
• US intake too high for
– Refined grains 
– Added sugars
2015 Dietary Guidelines
• Three dietary patterns associated with health 
benefits:
– Healthy US-style pattern
– Healthy Mediterranean-style pattern
– Healthy Vegetarian pattern
2015 Dietary Guidelines
DO DON’T
Fruits and vegetables Red or processed meats
Whole grains Refined grains
Low fat dairy Sugar-sweetened beverages
Seafood Sugar-sweetened foods
Legumes
Nuts
As long as we’re getting healthy…
…exercise matters too!
Ross R et al. Effects of exercise amount and 
intensity on abdominal obesity and glucose 
tolerance in obese adults: A randomized trial. 
Ann Intern Med. 2015;162:325. 
This study
300 obese adults: 4 groups followed for 24 wks with 
baseline and end measures of weight, waist 
circumference, glucose and insulin sensitivity.
Group Exercise duration Exercise intensity
Control Maintain baseline activity Maintain baseline activity
Low-Low 30 min per session Target 50% VO2 peak
High-Low 60 min per session Target 50% VO2 peak
High-High 40 min per session Target 75% VO2 peak
5 sessions per week for all groups
Results
• All 3 intervention groups lost weight and waist 
circumference (average 4 cm) c/w control 
group.
• No significant difference in glucose levels 
between intervention groups c/w control.
• High-low and High-high groups had improved 
insulin sensitivity c/w control.
• No significant difference between intervention 
groups in any measure. 
Moral of the story
• Patients don’t need to be scared of starting an 
exercise program
• Rapid walking pace (or slow jog!) of 4-5 mph for 
30 minutes 5x/wk will achieve the same goals (in 
this study) as running 4-5 miles 5x/wk.
• Also, probably just as good in smaller doses as 
long as the exercise equals 150 min/wk
• For patients starting exercise, recommend “10-
10-10”
Bronchiolitis
Updated guidelines from American Academy of 
Pediatrics
• Recommend not routinely administering 
inhaled bronchodilators (albuterol or 
epinephrine) to infants and children with 
bronchiolitis (Grade 2B)
• Change made because while they may provide 
short-term clinical improvement, they do not 
affect overall outcome, may have adverse  
effects, and increase total cost of care. 
• Can still be considered for infants and children 
with bronchiolitis and severe disease (eg, 
nasal flaring; retractions; grunting; respiratory 
rate >70 breaths per minute; dyspnea; or 
cyanosis) or respiratory failure
Previous guideline from 2006 
recommended a trial
Treating Obesity
Apovian CM. Pharmacologic Management of Obesity: AN Endocrine Society Clinical 
Practice Guideline.  J Clin Endocrinol Metab 2015.
• Endocrine Society-appointed task force of 
experts, methodologist, using GRADE system
– Diet, exercise, behavioral modification must be 
included in all approaches for BMI >25. (1****)
– Pharmacotherapy 
• BMI >27 with comorbidity or BMI >30 (2**)
– Bariatric surgery 
• BMI >35 with comorbity or BMI >40 
Treating Obesity
• Appropriate screening
• Identify/screen for secondary causes of obesity
• Identify medications that promote weight gain
• Follow 2013 AHA/ACC/TOS Guideline for 
management based on BMI and comorbidities
• Prescribe drugs that are weight neutral or 
promote weight loss
• Formulate treatment plan with diet, exercise, 
behavior modifications
Treating Obesity: Pharmacotherapy
• Use approved weight loss medications to
– Promote long term weight maintenance
– Ameliorate comorbidities
– Amplify adherence to behavior changes
• Assess safety and efficacy at 3 months (2**)
– Continue if >5% loss (1****)
– Titrate to maximum tolerable dose (2**)
• Use drugs for comorbidities that promote weight loss 
• Avoid sympathomimetic agents in pts with HTN or 
cardiovascular disease (1***)
• Avoid off-label use for weight loss alone (ungraded)
Treating Obesity: Pharmacotherapy
• If DM patients on insulin
– add metformin, GLP-1 agonist, or pramlintide
– Use basal insulin first
• In HTN pts
– Avoid beta blockers, use ACEI, ARB, CCB
Favor Avoid
DM (2***) Metformin 
Pramlintide
GLP-1 agonist 
Basal insulin 
Sulfonylurea
Mixed insulin
HTN (1****) ACEI
ARB
CCB
Beta-blocker
Depression (1***) Fluoxetine, sertraline
Imipramine
Bupropion 
Paroxetine
Tricyclic (amitriptylline)
mirtazapine
Psychosis (1***) ziprazidone Olanzapine
Quetiapine
Risperidone
Perphenazine
Contraception (2*) Oral contraceptives Injectable
Epilepsy (1***) Felbamate
Topiramate
Zonisamide
Gabapentin, Pregabalin
Vigabatrin
Valproic acid, Carbamazepine
Chronic inflammation (2***) DMDs, NSAIDS corticosteroids
Allergies  (2**) 2nd generation antihistamines 1st generation 
Treating Obesity
• Weight loss medications have not proven to 
have any sustained benefits after 
discontinuation
• Medications approved for long-term use:
– Orlistat 120 mg TID-approved in adolescents
– Phentermine/topiramate-7.5 mg/46 mg QD
– Lorcaserin-10 mg BID
– Naltrexone/bupropion 8 mg/90 mg- 2 tab BID
– Liraglutide- 0.6 to 3 mg SQ QD
Metformin
• Perhaps not an agent of evil in mild chronic 
kidney disease?
Background
• FDA restricts use of metformin 
in essentially any CKD due to 
its renal clearance and alleged 
association with lactic acidosis.
• But we know that metformin is 
the first-line drug for DM2 due 
to effects on weight and 
microvascular complications.
The study
Inzucchi SE et al. Metformin in patients with 
type 2 diabetes and kidney disease: A systematic 
review. JAMA. 2014;312:2668.
This study
• 65 trials over 4 decades, only one was an RCT.
• Baseline rate of lactic acidosis in patients with DM2 on 
metformin ranged from 3 – 10 per 100,000 person-
years.
– Not appreciably different from rate among all diabetics
• Lactic acid levels are slightly (but not clinically 
significantly) elevated in patients with CKD 3 on 
metformin.
• No correlation between metformin serum levels and 
risk of lactic acidosis or risk of complications of lactic 
acidosis. 
Take away points
• Lactic acidosis is rare even with metformin use 
in CKD.
• Metformin use in patients with mild-to-
moderate CKD (stage 1-3) is likely safe.
• Authors suggest:
– Using </= 2,000 mg metformin daily in GFR 45-60.
– Using </= 1,000 mg metformin daily in GFR 30-45.
– Monitoring closely and stopping metformin if CKD 
worsens.
Spironolactone and K+ screening
• Retrospective study of healthy young women taking 
spironolactone for acne. 
• Data from December 1, 2000, through March 31, 2014, 
were obtained from a clinical data repository. 
• Analyzed rates of hyperkalemia in 974 healthy young 
women taking spironolactone for acne. 
• Also analyzed 1165 healthy young women taking and 
not taking spironolactone to obtain a profile for the 
baseline rate of hyperkalemia in this population. 
• Main Outcomes and Measures The rate of 
hyperkalemia in healthy young women taking 
spironolactone for acne was calculated. Secondary 
measures included spironolactone prescriber profiles 
and potassium monitoring practices.
Results
• There were 13 abnormal serum potassium 
measurements in 1802 measurements obtained among 
young women receiving spironolactone therapy
• Hyperkalemia rate of 0.72%, equivalent to the 0.76% 
baseline rate of hyperkalemia in this population. 
• Repeat testing in 6 of 13 patients demonstrated normal 
values, suggesting that these measurements may have 
been erroneous. In the remaining 7 patients, no action 
was taken.
Conclusions and Relevance
• The rate of hyperkalemia in healthy young women 
taking spironolactone for acne is equivalent to the 
baseline rate of hyperkalemia in this population. 
Routine potassium monitoring is unnecessary for 
healthy women taking spironolactone for acne.
How to Age Gracefully
• Telomeres
– DNA sequences at the ends of chromosomes
– Prevent loss of genomic DNA
– Undergo attrition with normal cell division, 
oxidative stress, and inflammation
– Length is a biomarker of aging
– Shorter telomeres associated with decreased life 
expectancy and increased risk of chronic diseases
– Modifiable with lifestyle, dietary patterns
How to Age Gracefully
Crous- Bou M et al. Mediterranean diet and telomere length in Nurses’ Health Study: 
population based cohort study.  BMJ 2014; 349.
• Using NHS data, 4676 had telomere length measured and had 
completed FFQ’s
• Dietary adherence scored with Alternate Mediterranean Diet 
Score 0-9
• Greater adherence to Mediterranean Diet was associated with 
longer telomeres
• Controlled for BMI, smoking, physical activity, age
• A three point difference in adherence score corresponded to 
about 4.5 years of aging, similar to comparing smokers to 
nonsmokers
A Bridge (of anticoagulation) Too Far
Steinberg et al. Use and Outcomes Associated 
with Bridging During Anticoagulation 
Interruptions in Patients with Atrial Fibrillation 
(ORBIT-AF Trial). Circ. 2015;131:488.
The study
• Prospective observational study of 7,372 
patients on anticoagulation for atrial fib.
• 2,803 interruptions in therapy in 2,200 pts.
• Median follow up of 2 yrs.
• Outcomes: MI, stroke, VTE, major bleeding, 
hospitalization, death.
The study
• 24% of patients were bridged for procedures, 
with 73% of these using LMW-heparin. 
• Bridged pts: (1) more likely to have prior CVA 
or mechanical valve but (2) no difference in 
CHA2DS2-VASc score.
• Major bleeding: 5% of bridged pts, 1.3% of 
non-bridged pts (p<0.0001) for an OR of 3.84.
• Composite endpoint risk increased in bridged 
patients – OR 1.94 (p<0.0001)
In conclusion…
• Bridging anti-coagulation for procedures is 
common – and of unclear benefit.
• Some procedures – e.g., dental work – can be 
done safely without interruption in oral 
anticoagulation
• Bridging oral anticoagulation is associated 
with increased bleeding risk and CV risk and 
should only be used in carefully selected 
patients. 
Just one more thing about A fib
• Scheuermeyer FX et al. Emergency 
department patients with atrial fibrillation or 
flutter and an acute underlying medical illness 
may not benefit from attempts to control rate 
or rhythm. Ann Emerg Med 2014; published 
online at 
http://dx.doi.org/10.1016/j.annemergmed.20
14.09.012
The gist of the study
• 416 patients in 2 Canadian EDs over 1 yr
presenting with atrial fib/flutter and at least one 
other acute medical issue:
– 105 treated with rate control
– 30 treated with rhythm control
– 281 treated with neither (supportive care only)
• 40.7% of rate/rhythm control had an adverse 
event
• 7.1% of supportive care group had an adverse 
event
Take away?
• Maybe some patients with atrial fib/flutter are 
like patients who present with sinus 
tachycardia – the underlying issue needs to be 
treated, not just the heart rhythm/rate. 
• Maybe the message is:
– If a patient has isolated atrial fib with RVR, by all 
means treat it.
– If a patient has atrial fib and tachycardia due to 
underlying disease, treat that first. 
Artificial sweeteners 
Suez J. et al.  Artificial sweeteners induce glucose intolerance by altering the gut 
microbiota.  Nature 2014.  514.  181-6.
• Background:
– Six NAS approved by FDA- most are not absorbed and pass 
through the gut unaltered
– Controversial safety profiles
• Little induction of glycemic response
• May contribute to weight gain and type 2 DM
• Study comparing metabolism in MICE fed chow and liquid  
(water, glucose, sucrose, aspartame, saccharin, sucralose) 
diets
Artificial Sweeteners
• Results:
– Mice fed NAS all developed glucose intolerance, 
whereas glucose and sucrose-fed controls did not.
– Fecal microbiota significantly changed
– Fecal transplantation from NAS-fed mice induced 
glucose intolerance in normal chow-fed mice
Artificial Sweeteners
• And what about humans? 
• The researchers verified correlation between NAS use and 
glucose intolerance in survey data AND
• Followed 7 healthy adult volunteers fed saccharin for a 
week with continuous glucose monitoring and daily GTT
– 4/7 developed significantly worse glucose response on days 5-7, 
none improved
• Perhaps it’s time to decline the pink and blue packets…
This one is for Mark!
• Murphy D, Oshin F. Reptile associated salmonellosis in children 
aged under 5 years in South West England. Arch Dis Child 
2015;100:364-365.
• 27% of salmonellosis cases 
had exposure to reptiles
• Reptile associated 
salmonellosis cases were 2.5 
times as likely to be 
hospitalized as those not 
associated with reptile 
exposure. 
D is for Debacle? Dilemma? Don’t Do it?
• USPSTF (LaFevre, Ann Intern Med, Nov 2014)
– Insufficient evidence to recommend screening for Vitamin 
D deficiency in asymptomatic adults
• Accuracy of tests unknown
• No clear threshold
• Causes of Vit D Deficiency (obesity, low sun exposure, dark skin, 
low intake) not clearly associated with adverse outcomes
– Harms of treatment are small
– Treatment of Vit D deficiency does NOT improve outcomes 
• Cancer
• DM
• Fracture risk
• Death
One more note on Vit D…
• USPSTF DOES still recommend vitamin D 
supplementation and exercise for community-
dwelling adults >65 who are at high risk of 
falls
Are we overprescribing statins?
DeFilippis AP et al. An Analysis of Calibration and 
Discrimination Among Multiple Cardiovascular Risk 
Scores in a Modern Multiethnic Cohort. Ann Intern 
Med 2015;162(4):266.
• Looked at 4227 pts and compared observed to 
expected events using 5 commonly used risk 
calculators, including the AHA- ACC-ASCVD score.
This study found…
• Fairly dramatic over-representation of risk of CV 
events using 4 of the most common risk 
calculators:
– 37-154% over-estimation of risk for men
– 8-67% over-estimation of risk in women
• Reynolds Risk Score performed the best for men 
(9% over-estimation in men, 21% under-
estimation in women) but requires hs-CRP.
• If duplicated, this study calls into question how 
we determine who gets statins
Community Acquired Pneumonia
Guidelines recommend using either monotherapy with a 
fluoroquinolone or combination therapy with a β-lactam 
plus a macrolide or a fluoroquinolone as empirical 
treatment for patients with suspected community-
acquired pneumonia (CAP) who require hospitalization 
but not intensive care unit (ICU) admission
• Investigators in the Netherlands have 
compared β-lactam monotherapy, 
fluoroquinolone monotherapy, and β-lactam–
macrolide combination therapy with respect 
to 90-day mortality.
• Between February 2011 and August 2013, 2283 patients at 
seven hospitals were enrolled. 
• A microbial etiology was determined in only a minority of 
them, with Streptococcus pneumoniae (15.9%) and 
Haemophilus influenzae (5.8%) most commonly identified, and 
“atypical” pathogens found in only 2.1%. 
• Noninferiority analyses showed no significant difference in 90-
day mortality rates — crude or adjusted — among the three 
regimens in the intent-to-treat or antibiotic-adherent 
populations. 
• There were also no clinically relevant differences in hospital 
length of stay or rates of major or minor complications. 
• The shift from intravenous to oral antibiotic therapy occurred 
earlier with fluoroquinolone monotherapy than with either of 
the other two regimens (median, 3 vs. 4 days).


Atypical Hyperplasia of Breast
• 10% of benign breast biopsies
• Associated with a 30% risk of breast cancer in 25 years (RR 
of 4), cumulative risk of 1% per year. 
• SERMs and aromatase inhibitors can reduce cancer risk 41-
79% (cf 38%)
– Am Soc Clin Oncology recommends considering 
chemoprevention in women with projected absolute risk of 
1.7%
– USPSTF: moderate certainty of benefit for women with 
estimated risk of 3% over 5 years
• Currently not recommended for high-risk screening with 
MRI 
– Recommended for pts with hereditary risk of 20-25%
Atypical Hyperplasia of Breast:
What do we do? 
• Discuss risks and benefits of 
chemoprophylaxis with patients
• Consider MRI screening in addition to 
mammography
• Advocate for further research
‘Roids and pneumonia
• Blum CA et al. Adjunct prednisone therapy for 
patients with community-acquired 
pneumonia: A multicentre, double-blind, 
randomised, placebo-controlled trial. Lancet
2015. Published online at 
http://dx.doi.org/10.1016/S0140-
6736(14)62447-8
This study
• Double-blind, placebo-controlled, multi-centered.
• 785 patients over 5 years, hospitalized with 
community acquired pneumonia:
– assigned prednisone 50 mg/day x 7 days or placebo
• Time to “clinical stability” was 3 days for 
prednisone group, 4 days for placebo group
• Prednisone group discharged one day earlier than 
placebo group.
Prednisone and pneumonia
• Increased incidence of hyperglycemia requiring 
insulin in the prednisone group (19% vs 11%).
• 30 day complication rates were the same (trend 
toward lower rate in the prednisone group). 
• My take away: not standard of care, but no harm 
in giving steroids to COPD patients with 
pneumonia or adding as adjunct in patients who 
are not immunosuppressed at baseline. 
Screens and Sleep
• Background
– Inadequate sleep is a risk factor for
• Obesity
• Poor school performance
• Somatic health
• Psychosocial health
• Risk-taking behaviors
• HTN
• CHD
• Stroke
• Immunity
Screens and Sleep
• TV viewing is a risk factor for 
– Weight gain
– Decreased academic achievement
– Behavioral problems
• TV in bedroom and TV viewing associated with
– Shorter sleep duration
– Later bedtimes
• Interactive screens may be more disruptive 
because they are not as passive.
Screens and Sleep
Falbe J, et al.  Sleep Duration, Restfulness, and Screens in the Sleep Environment.  
Pediatrics Feb 2015.  135 (2) e367
• 2048 Massachusetts fourth and seventh graders  enrolled in 
Massachusetts Childhood Obesity Research Demonstation
Study (MA-CORD) from two MA communities with lower-
than-average  for state income
• Primary outcomes: 
– Weekday sleep duration (estimated by bed-and waketimes)
– Perceived insufficient rest or sleep  (# days in past week)
Screens and Sleep
• Results:
– 75% of kids had TV in sleeping room
– 54% had small screen (7th gr 65%, 4th gr 46%)
– Sleeping in rooms with screens associated with less 
sleep time (due to later bedtime)
• TV – 18 min
• small screen – 20.6 min 
– Screen time associated with shorter sleep duration 
• 3.7 min per hour TV 
• 9.8 min per hour games
– Small screens (PR 1.39)  and screen time (PR 1.05 per 
hour) associated with perceived insufficient rest 
Screens and Sleep
• Why?
– Displaced time
– Consumption of advertised caffeinated beverages
– Circadian rhythm disturbance
– Increased arousal
• What next?
– Association is not causation, but I will encourage
• Limiting screen time
• No TV in bedroom
• No smartphones/small screens in bedroom
Concussions and Rest
Thomas DG et al.  Benefits of Strict Rest After Acute Concussion: A Randomized Controlled Trial.  
Pediatrics 2015 Jan 5.  
• 99 adolescents (age 11-22) with ED diagnosis of mTBI
– Usual care (median 2 days)
– Strict bed rest (5 days)-no school, work, or physical activity
– Stepwise return to activity following rest and symptom resolution
– Daily neurocognitive tests(ImPACT), balance assessments, PCSS, 
activity diaries for 10 day follow up
Concussions and Rest
• Both groups decreased physical activity by 
~20% in first 5 days
• Usual care group more mental activity days 2-
5 (8.33 vs 4.86 hours)
• 60% recovered completely (PCSS <7) by day 10
Concussions and Rest
• Strict Rest group
– Greater PCSS scores over entire FU (188 vs 132)
• Higher physical symptom scores day 2, 3
• Higher emotional symptoms scores throughout
– Higher total number of symptoms reported
– No significant differences in neurocognitive tests 
or balance scores at 3, 10 days. 
– Differences greater for those with past concussion 
or concussion based on symptoms (HA, dizzy) vs 
immediate signs (LOC, amnesia, confusion)
Concussion and Rest
• Strict rest may not be the best 
recommendation
• Follow up needed (vs ED recommendations 
only)
Make the kids wash the dishes:
more support for the hygiene hypothesis
Hesselmar et al.  Allergy in children in hand vs. machine dishwashing.  Pediatrics 2015;  135 (3).  
• Kids who grew up in homes where the dishes 
were washed by hand had lower incidence of 
allergic disease (OR 0.57) than those who 
grew up with a machine dishwasher. 
– Effects more pronounced (0.33) in families who
• Purchased unpasteurized food from farms.
• Eat fermented food.
Smoking Cessation
• Walker N et al. Cytisine versus Nicotine for 
Smoking Cessation. N Engl J Med 
2014;371:2353. 
This study
• 1310 adult daily smokers randomized to 
– cytisine tablets for roughly 25 days
– NRT (patches plus gum or lozenges) for 8 weeks
– Both got behavioral support via 3 brief phone calls 
over 8 wks.
• Outcome: self-reported continuous abstinence at 1 
month 
– Higher in cytisine group c/w NRT (40% vs. 31%). 
– Similarly, abstinence rates favored cytisine at 2 
and 6 months. 
– Cytisine had more adverse events (mostly nausea, 
vomiting, and sleep disorders) with 5% 
discontinuation rate due to side effects.
HIV testing
Updated guidelines – June 2014
• CDC’s new testing algorithm allows diagnosis of HIV 
as much as 3-4 weeks earlier than the previously 
recommended sequence of tests using the Western 
blot. 
• As a result, the HIV-1 Western blot is no longer part 
of the recommended algorithm. The new algorithm 
should be used for follow-up testing. 
